Oryzon Genomics SA (ORY) — Cash Flow Quality Index
Oryzon Genomics SA (ORY) has a Cash Flow Quality Index of -2.29x as of June 2023. Operating cash flow of €-2.41 Million is below net income of €1.05 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how much of Oryzon Genomics SA's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Oryzon Genomics SA Cash Flow Quality Index (2014–2014)
Historical Cash Flow Quality Index for Oryzon Genomics SA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Oryzon Genomics SA to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Oryzon Genomics SA (2014–2014)
Year-by-year earnings quality comparison for Oryzon Genomics SA. For live market cap and the full company financial profile, see Oryzon Genomics SA market cap and net worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2014 | 1.82x | €12.13 Million | €6.65 Million | — |